Lotus Pharmaceutical Co., Ltd. (1795.TW)

309,50 +4,50 (+1,48%) Alla chiusura: 01:30PM CST

Lotus Pharmaceutical Co., Ltd.

No. 277 Song Ren Road
17th Floor Xin Yi District
Taipei 110
Taiwan
886 2 2700 5908
https://www.lotuspharm.com.tw

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Petar Antonov Vazharov	CEO & Director	34,72M	N/D	N/D
Mr. Zenon Zdunek	Vice President of Supply Chain & Operations	12,83M	N/D	N/D
Ms. Eeling Chan	Chief Financial Officer	5,19M	N/D	N/D
Ms. Gwen Hsieh	Chief Information Officer	N/D	N/D	N/D
Ms. Yu-Ying Yang	Associate Director of Co-Operate Communication	N/D	N/D	N/D
Boon Chong Tan	Deputy General Manager	N/D	N/D	N/D
Mr. Edin Buljubasic	Vice President	N/D	N/D	N/D
Yingming Yue	Vice President	N/D	N/D	N/D
Valerie Lau	Chief Commercial Officer-APAC	N/D	N/D	N/D
Mr. Manish Chawla	Vice President of Research and Development	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in TWD.

Descrizione

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Governance aziendale

L'ISS Governance QualityScore di Lotus Pharmaceutical Co., Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.